Teva Pharmaceutical Balance Sheet - Quarterly (NYSE:TEVA)

Add to My Stocks
$24.83 $0.19 (0.77%) TEVA stock closing price Sep 20, 2018 (Closing)

A thorough fundamental analysis involves using data from Teva Pharmaceutical balance sheet, apart from other financial statements, to value the business. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Teva Pharmaceutical stock analysis. A company releases its balance sheet every quarter along with its quarterly results. Teva Pharmaceutical had a long term debt of $28.97B at the end of 2018 Q2. To understand the debt servicing capacity of the company, one needs to look at Teva Pharmaceutical operating cash flow and Teva Pharmaceutical revenue also. Teva Pharmaceutical debt to equity ratio is 1.56.

View and download Teva Pharmaceutical quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Cash1.86B1.42B963M680M599M900M988M1.56B6.98B5.96B
Marketable Securities-------1.06B--
Receivables6.06B6.29B7.13B7.42B7.32B7.26B7.52B8.07B5.37B5.19B
Inventory4.97B5.11B4.92B5.06B5.13B5B4.95B5.35B3.92B3.96B
Raw Materials1.65B1.7B1.64B1.7B1.64B1.57B1.58B1.88B-1.43B
Work In Progress605M646M597M612M605M568M538M637M-525M
Finished Goods2.71B2.77B2.69B2.75B2.89B2.87B2.83B2.83B-2.01B
Notes Receivable----------
Other Current Assets1.82B1.87B2.37B3.06B1.54B1.67B3.5B1.35B2.07B1.88B
Total Current Assets
14.71B14.69B15.38B16.23B14.6B14.84B16.96B17.39B18.34B16.99B
Property Plant & Equipment11.96B12.09B12.18B12.38B12.25B12.15B11.93B12.24B--
Accumulated Depreciation4.75B4.67B4.51B4.38B4.2B3.99B3.85B3.86B--
Net Property Plant & Equipment
7.21B7.42B7.67B8B8.04B8.16B8.07B8.38B6.69B6.63B
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges440M463M574M536M773M747M725M1.07B--
Intangibles43.86B45.78B46.05B60.27B61.7B66.22B65.9B69.85B30.24B28.84B
Deposits & Other Assets806M832M932M1.05B1.25B1.32B1.24B2.06B2.64B2.66B
Total Assets
67.03B69.18B70.62B86.08B86.36B91.28B92.89B98.75B57.92B55.13B
Notes Payable--------2.77B1.3B
Accounts Payable1.78B1.93B2.07B2.37B2.28B2.38B2.16B4.95B3.86B3.53B
Current Portion Long-Term Debt1.27B1.3B3.65B2.73B1.25B1.94B3.28B4B2.88B1.58B
Current Portion Capital Leases----------
Accrued Expenses2.92B3.24B3.56B3.3B3.47B3.16B4.26B---
Income Taxes Payable----------
Other Current Liabilities8.24B8.29B8.64B8.55B8.46B8.42B8.82B10.33B7.67B7.8B
Total Current Liabilities
14.22B14.76B17.92B16.94B15.46B15.9B18.52B19.29B14.41B12.91B
Mortgages----------
Deferred Taxes/Income2.67B3B3.28B4.91B5.45B5.29B5.22B7.86B2.1B1.7B
Convertible Debt----------
Long-Term Debt28.97B29.45B28.83B31.97B33.81B32.69B32.52B33.18B8.04B8.62B
Non-Current Capital Leases----------
Other Long-Term Liabilities1.81B1.88B1.84B1.96B2.04B1.64B1.64B1.39B1.35B1.31B
Total Liabilities
47.66B49.08B51.87B55.79B56.75B55.53B57.9B61.72B25.9B24.54B
Minority Interest----------
Preferred Stock3.76B3.7B3.63B3.62B3.62B3.62B3.62B3.62B3.62B3.62B
Common Stock Net54M54M54M54M54M54M54M54M52M52M
Capital Surplus23.43B23.44B23.48B23.47B23.44B23.41B23.41B23.37B18.24B18.1B
Retained Earnings-2.86B-2.69B-3.8B7.87B7.43B13.81B13.61B14.99B14.99B15.11B
Treasury Stock4.15B4.15B4.15B4.15B4.15B4.16B4.19B4.2B4.2B4.21B
Other Liabilities-859M-254M-467M-573M-786M-992M-1.5B-807M-671M-2.08B
Shareholders Equity19.37B20.1B18.75B30.3B29.61B35.75B34.99B37.03B32.02B30.59B
Total Liabilities & Shareholders Equity67.03B69.18B70.62B86.08B86.36B91.28B92.89B98.75B57.92B55.13B
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at Teva Pharmaceutical historical stock prices and the current Teva Pharmaceutical stock price can tell you how the stock price has moved, whereas the Teva Pharmaceutical PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: Anything that the Teva Pharmaceutical company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Teva Pharmaceutical had total assets of $67.03B.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. TEVA stock had total liabilities of $47.66B for the quarter 2018 Q2.

Teva Pharmaceutical Balance Sheet - Key Ratios

Current ratio
1.04
Debt to equity ratio
1.56
Asset turnover ratio
0.28
Receivables turnover
3.04
Price to book ratio
1.06

Quarterly Balance Sheets For Teva Pharmaceutical Industries Ltd (ADR) Peers

Allergan balance sheet, Astrazeneca balance sheet, Eagle Pharma balance sheet, Fortress Biotech balance sheet, Mylan balance sheet